New injection shows promise for stubborn high cholesterol
NCT ID NCT07391722
First seen Feb 06, 2026 · Last updated May 06, 2026 · Updated 12 times
Summary
This study tests a new medicine called DNV001, given as a shot, to see if it can lower bad cholesterol (LDL-C) in people whose cholesterol is still high despite taking statins. About 120 adults will receive different doses of DNV001 or a placebo for 36 weeks, while continuing their usual statin. The main goal is to measure how much LDL-C drops after 24 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.